Trial
NCT05018728
The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Pfizer
Condition
Sickle Cell Anemia in Children
Intervention
Voxelotor
Why stopped
This study was terminated on September 26, 2024 due to voluntary withdrawal of study drug from the market.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-12